Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,600 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Follow-Up Questions
¿Quién es el CEO de Artivion Inc?
Mr. James Mackin es el Chairman of the Board de Artivion Inc, se unió a la empresa desde 2014.
¿Qué tal es el rendimiento del precio de la acción AORT?
El precio actual de AORT es de $46.53, ha increased un 1.68% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Artivion Inc?
Artivion Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Artivion Inc?
La capitalización bursátil actual de Artivion Inc es $2.1B
¿Es Artivion Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 9 analistas han realizado calificaciones de análisis para Artivion Inc, incluyendo 4 fuerte compra, 7 compra, 2 mantener, 0 venta, y 4 fuerte venta